ABSTRACT
INTRODUCTION
Osteoclasts are bone-resorbing multinuclear giant cells which are differentiated from macrophage! monocyte lineage precursors. [1] [2] [3] In patients with bone-resorbing disorders, such as rheumatoid arthritis and osteoporosis, increased numbers of activated osteoclasts cause the bone destruction seen in such diseases. 4, 5 It has been established that osteoclastogenesis is mainly regulated by the RANK (the receptor activator of nuclear factor κB)! RANKL (RANK ligand) system. However, the mechanism whereby osteoclast precursors fuse with each other to form a polykaryon was until recently a mystery. 6, 7 The tetraspanins, also referred to as the transmembrane-4 superfamily (TM4SF), are characterized by their four transmembrane domains and comprise at least 20 distinct members in mammalian hematopoietic cells, including CD9, CD37, CD53, CD63, CD81 and CD151. [8] [9] [10] [11] One of the tetraspanins, CD9, is a membrane glycoprotein (about 25 kDa), which is expressed in a variety of cell types, and has been implicated in the regulation of cell fusion during osteoclastogenesis. 12, 13 However, virtually nothing is known about the expression of different types of tetraspanin proteins in osteoclasts, except for CD9. Because multinucleation (i.e., polykaryon formation) is a characteristic of osteoclasts that distinguishes them from all other somatic cells, the identification of the molecules responsible for this event is expected to lead to the development of novel therapeutic agents for controlling bone-resorbing diseases. To see the whole views of regulation of osteoclast formation with tetraspanin family proteins, it is necessary to encompass the cyclopedic lists of tetraspanin expressed in osteoclasts.
In this study, using RT-PCR methods with transcript-specific primers, we investigated the mRNA expression of the tetraspanin family proteins expressed in an osteoclast precursor cell line, RAW 264.7. Furthermore, in order to identify the functions of two of the tetraspanin expressed proteins, we examined the effect of targeted inhibitions by using short interfering RNAs.
METHODS

CELL CULTURE
RAW264.7, a murine macrophage! monocyte lineage cell line, was obtained from ATCC (ATCC#: TIB-71), and cultured with α-MEM (Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS; HyClone, Logan, UT, USA) and penicillin! streptomycin (Invitrogen). 13 RAW264.7 can fully differentiate into mature osteoclast-like cells by stimulation with RANKL, and is therefore commonly used for a model system of in vitro osteoclastogenesis. 14 In order to differentiate the cells into multinuclear osteoclasts, 50 ng! ml RANKL (PeproTech, Rocky Hill, NJ, USA) was added to the medium and incubated for 3 5 days.
RT-PCR AMPLIFICATION
Total RNAs of RAW264.7 cells were extracted using TRIzol TM reagent (Invitrogen) and cDNAs were synthesized with SuperScript III reverse transcriptase (Invitrogen), according to the manufacturers' protocol. To eliminate genomic DNA contamination, we treated the RNA samples with DNaseI (Takara, Kyoto, Japan) before cDNA synthesis. Specific primer pairs (listed in Table 1 ) were used to amplify cDNA. PCR amplification was performed for 25 cycles at 95 for 45 seconds, at 55 for 30 seconds, and at 72 for 1 minute. The products were electrophoresed on 2% agarose gel. The amplified PCR products were confirmed by their nucleotide sequencing using ABI Dye terminator cycle sequencing with the ABI PRISM 310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA).
QUANTITATIVE REAL-TIME PCR
Relative quantification with real-time RT-PCR was performed using an ABI PRISM 7900 (Applied Biosystems) with an Assay-on-Demand TaqMan probe and relevant primers (Tspan-5, Assay ID #Mm 00497960_m1; NET-6 (Tspan-12), Assay ID #Mm 00481226_m1; GAPDH, Assay ID #Mm99999915_g1), according to the manufacturer's instructions. Isolation of total RNA from RAW264.7 cells and cDNA synthesis were performed as described above. Each sample was assayed in triplicate and the median threshold cycle (Ct) value was used to calculate the relative concentration of transcripts. Values were normalized against the level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
RNA INTERFERENCE
A small interfering RNA duplex (siRNA) targeting Tspan-5 and NET-6, and the control RNA duplex were synthesized by, and purchased from, B-Bridge International Inc. (Sunnyvale, CA, USA): Tspan-5 siRNA, 5'-GGAUCAAAGACCAGCUGUATT-3', and NET-6 siRNA, 5'-GCUAAUUGGGGAGCUGUAAAATT-3'. The synthesized 21-mer sense and antisense RNA strands were hybridized. The transfection of hybridized siRNAs into RAW264.7 cells was performed using LipofectAmine2000 (Invitrogen) according to the manufacturer's instructions. After transfection, the cells were incubated for 3 days in α-MEM supplemented with 10% FCS and antibiotics. Then, the cells were fixed in citrate acetone fixative, stained for tartrate-resistant acid phosphatase (TRAP) with a staining kit (Sigma-Aldrich, St. Louis, MO, USA), and observed by an inverted differential interference microscope (IX-71, Olympus, Tokyo, Japan), equipped with a 20X objective (UPLSAPO, Olympus; N.A. 0.75). The picture image was acquired on-line through a 
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GGA GGT A CCA T GA A GGA T T T T s p a n -2 5 2 3 T T CA CA A CA A GA GCCT CA CA CT A T GT CT T CA T CA CCT A T G T s p a n -3 6 7 6 T GT CCT GT A GCCA CT T CT CA A A GGGT CCT GA A GT CA GT T G T s p a n -5 5 5 6 GA A GCA A T A CT GT A GT GT GT T A CT GA T CA CCA A CT T CCT A T s s c 6 cooled CCD (ORCA 3CCD; Hamamatsu Photonics, Hamamatsu, Japan) and processed with data acquisition software (Aquacosmos; Hamamatsu Photonics). For the evaluation of osteoclastogenesis, nuclei of multinucleated (more than four nuclei) TRAP-positive cells were counted using light microscopy. More than 1000 nuclei in ten visual fields from three independent experiments were counted. The reduction of the amount of mRNAs in the targeted cells by these siRNAs was assessed by conventional RT-PCR using their specific primers, as described above. The expression of NFATc1 was also assessed by conventional RT-PCR as previously described. 15 
STATISTICS
All results are expressed as the mean ± standard error (s.e.m.) obtained from n experiments. Statistical differences were evaluated by unpaired Student's ttests. Statistical probability values of p < 0.05 were considered to indicate significant differences.
RESULTS
EXPRESSION PROFILE OF TETRASPANIN SU-PERFAMILY PROTEINS IN AN OSTEOCLAST PRECURSOR CELL LINE
In the RT-PCR analysis of total RNA extracted from RAW264.7 cell lines cultured in the absence or presence of RANKL-stimulation, oligonucleotide primers for 12 kinds of tetraspanin superfamily proteins showed an amplification of products of expected sizes (Fig. 1A) : CD9, CD37, CD53, CD63, CD81, CD82, CD151, NAG-2, NET-6, SAS, Tspan-3, and Tspan-5. These amplified products were confirmed by their nucleotide sequencing. As a control, the presence of mRNA for GAPDH was examined, and it was found to be present at the expected molecular sizes (Fig. 1A) .
Upon RANKL stimulation, mRNA for Tspan-5 was shown to be up-regulated, whereas that for NET-6, on the other hand, was down-regulated (Fig. 1A) . On the other hand, the expression of other tetraspanins, i.e., CD9, CD37, CD53, CD63, CD81, CD82, CD151, NAG-2, SAS, and Tspan-3 were not significantly altered at least in mRNA levels.
Expression of Tspan-5 and NET-6 was also examined quantitatively by real-time RT-PCR using a TaqMan probe and relevant primers (Fig. 1B) . Upon stimulation of osteoclastogenic RANKL signaling, Tspan-5 mRNA was promptly increased to 2.5-folds in 1 day after, and the up-regulation was sustained for up to 4 days (Fig. 1B, upper panel) . On the other hand, the transcription of NET-6 was down-regulated to about 1! 5 one day after RANKL stimulation but its level was gradually recovered (Fig. 1B, lower panel) . This result may suggest that the suppression of NET-6 expression is important in the earlier phase of osteoclastogenic cell fusion.
TARGETED INHIBITION OF TWO TETRASPANIN PROTEINS, TSPAN-5 AND NET-6
Of the 12 tetraspanin proteins expressed in RAW 264.7 cells, we took special notice of Tspan-5 and NET-6, because their expressions are changed in response to RANKL stimulation, suggesting their significant roles in osteoclastogenesis. To investigate the role of these tetraspanin proteins on osteoclastogenesis, we examined the effect of inhibiting their functions with short interfering RNAs (siRNAs) targeting mouse Tspan-5 and NET-6 (Fig. 2) . The siR-F i g . 1 ( A) RT -P CR a n a l y s i s o f mRNA e n c o d i n g 1 7 d i f f e r e n t k i n d s o f ma mma l i a n t e t r a s p a n i n s u p e r f a mi l y p r o t e i n s e x p r e s s e d i n a n o s t e o c l a s t p r e c u r s o r c e l l l i n e , RA W2 6 4 .
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NAs and its control RNA duplex were generated and transfected into RAW264.7 cells. According to the basic experiments for expressing green fluorescent protein, the transfection efficiency in these cell types was estimated to be approximately 40 60% (data not shown). 13 The reduction of the amount of Tspan-5 and NET-6 mRNAs in the targeted cells by these siRNAs was assessed by RT-PCR using gene specific primers ( Fig. 2A) . These siRNA potently inhibited the mRNA expression to about 50% in Tspan-5 ( Fig. 2 Aa) or to about 60% in NET-6 (Fig. 2Ab) at the transcript levels. On the other hand, the transcription of NFATc1, a transcription factor crucial for osteoclastogenesis 16 ( Fig. 2A, lower panels) , as well as those of other osteoclast markers, such as c-fos, RANK and αv integrin (data not shown), were not significantly altered, suggesting that neither Tspan-5 nor NET-6 are involved in general osteoclastogenic signaling cascades. Next, the transfection cells were cultured for 3 days in the presence of RANKL to induce differentiation. The results showed that the formation of osteoclast-like polykaryons was reduced by the inhibition of Tspan-5 expression (Fig. 2Bb) . Interestingly,
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DISCUSSION
One of the major characteristics of bone-resorptive osteoclasts is cell fusion and multinucleation during their maturation into giant polykaryons. Tetraspanins are well known to be critically involved in the process of cell fusion, which includes osteoclastogenesis. 12, 13, [16] [17] [18] [19] [20] Nevertheless, the tetraspanin superfamily consists of at least 20 subtypes, and it is still unsolved which subtypes are specifically responsible for osteoclastogenesis. In the current study, we revealed the redundant expression of mRNAs for 12 members among 17 mammalian hematopoietic tetraspanins, such as CD9, CD37, CD53, CD63, CD81, CD82, CD151, NAG-2, NET-6, SAS, Tspan-3, and Tspan-5. We found that two of the tetraspanin proteins, Tspan-5 and NET-6, are dynamically regulated by osteoclastogenic RANKL signaling at the transcriptional level. This case shows a marked contrast to that of CD9, whose membrane localization (especially to a specific membrane microdomain called "lipid raft") is regulated by RANKL stimulation. 13 Regarding the role of tetraspanins in osteoclastogenesis, there is some controversy. Although most previous reports have indicated that tetraspanins are crucial for the formation of polykaryons including osteoclasts, 13, [17] [18] [19] [20] [21] one report has shown that tetraspanins such as CD9 and CD81 do not promote but rather inhibit multinucleated osteoclast formation, by using CD9-and CD81-global knockout mice. 12 Given the severe redundancy and crucial role of tetraspanins in osteoclasts, we can reasonably speculate that some other tetraspanins, i.e., CD37, CD53, CD63, CD82, CD151, NAG-2, NET-6, SAS, Tspan-3, and Tspan-5, are up-regulated and possibly compensate the losses-of-function of CD9 and CD81.
Of the 12 expressed tetraspanins, two molecules, Tspan-5 and NET-6, are worthy of note, because their mRNA expressions are altered upon stimulation by RANK! RANKL signaling, and they have reciprocal roles in osteoclastogenesis. This case shows a marked contrast to that of CD9, whose membrane localization (especially to a specific membrane microdomain called "lipid raft") is regulated by RANKL stimulation. 13 Tspan-5, whose expression in osteoclast precursors was up-regulated by RANKL and thus has a positive regulator of osteoclast maturation, has previously been shown to be abundantly expressed in the brain and to be involved in the development of the central nervous system. [22] [23] [24] It has also been reported that Tspan-5 is expressed in unique natural killer (NK) cell subsets detected in the uterine decidua in early pregnancy. 25 NET-6, also referred as Tspan-13, a negative regulator of osteoclastogenesis, is known as a kind of aberrantly expressed cell marker in breast cancers, and is thought to play a role in mammary neoplasia. 26 Despite the studies revealing the expression profiles, the specific function of these tetraspanins, Tspan-5 and NET-6, remained unsolved.
It is an intriguing, but still unanswered, question how these different tetraspanin proteins exhibit contradictory functions in cell fusion. In general, tetraspanin proteins are known to function as organizers of multimolecular membrane complexes ("tetraspanin web"), by composing a certain lipid microdomain, designated as a "tetraspanin-enriched microdomain (TEM)". 10, 11 Then it can be suggested that Tspan-5 and NET-6 form their webs cooperatively or respectively on the cell membrane and recruit unknown cisinteracting partners important for osteoclast cell fusion. Otherwise, they may behave competitively to unknown ligands for stimulating cell fusion. Further studies are needed to clarify the molecular functions of tetraspanin proteins in this scheme.
In conclusion, we revealed the redundant expression of the tetraspanin superfamily proteins in osteoclast precursor cell lines CD9, CD37, CD53, CD63, CD81, CD82, CD151, NAG-2, NET-6, SAS, Tspan-3, and Tspan-5, and specific reciprocal functions of Tspan-5 and NET-6. This finding may contribute to an overall understanding of tetraspanin-regulated cell fusion during osteoclastogenesis, which has recently emerged as a novel therapeutic target for boneresorbing disorders.
